Chicago Capital, LLC Moderna, Inc. Transaction History

Chicago Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	SELL	$85.37 - $115.44 $16,817 - $22,741	-197 Reduced 9.15%	1,955 $208,000
Q2 2023 Jul 20, 2023	BUY	$118.5 - $160.53 $23,344 - $31,624	197 Added 10.08%	2,152 $261,000
Q3 2022 Oct 14, 2022	SELL	$118.07 - $194.18 $3,896 - $6,407	-33 Reduced 1.66%	1,955 $231,000
Q2 2022 Jul 21, 2022	SELL	$117.13 - $176.59 $5,856 - $8,829	-50 Reduced 2.45%	1,988 $284,000
Q4 2021 Jan 20, 2022	SELL	$225.82 - $368.51 $16,259 - $26,532	-72 Reduced 3.41%	2,038 $518,000
Q3 2021 Oct 28, 2021	SELL	$221.9 - $484.47 $28,847 - $62,981	-130 Reduced 5.8%	2,110 $812,000
Q2 2021 Jul 22, 2021	SELL	$129.91 - $234.98 $649 - $1,174	-5 Reduced 0.22%	2,240 $526,000
Q4 2020 Jan 25, 2021	BUY	$65.74 - $169.86 $147,586 - $381,335	2,245 New	2,245 $235,000

953

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $16.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Chicago Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Chicago Capital, LLC with notifications on news.